12/2
07:30 am
bctx
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
Medium
Report
BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025
11/25
07:30 am
bctx
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
High
Report
BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025
11/20
07:30 am
bctx
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
Medium
Report
BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics
11/18
07:30 am
bctx
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
Medium
Report
BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025
11/7
09:28 am
bctx
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025 [Canadian Business Journal (Canada)]
High
Report
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025 [Canadian Business Journal (Canada)]
11/7
07:30 am
bctx
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
High
Report
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025
11/4
07:30 am
bctx
BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models
Medium
Report
BriaCell to Present Robust Anti-Cancer Activity of Bria-OTS+™ in Breast and Prostate Cancer Models
10/22
07:30 am
bctx
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
Medium
Report
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
10/21
07:50 am
bctx
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
Low
Report
BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study
10/21
07:30 am
bctx
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer
Low
Report
BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer
10/20
09:28 am
bctx
BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025 [Canadian Business Journal (Canada)]
Low
Report
BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025 [Canadian Business Journal (Canada)]
10/20
07:30 am
bctx
BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025
Low
Report
BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025
10/13
09:28 am
bctx
BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025 [Canadian Business Journal (Canada)]
Medium
Report
BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025 [Canadian Business Journal (Canada)]
10/13
07:30 am
bctx
BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025
High
Report
BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025
10/3
09:28 am
bctx
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting [Canadian Business Journal (Canada)]
Low
Report
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting [Canadian Business Journal (Canada)]
10/3
07:44 am
bctx
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting [Yahoo! Finance]
Low
Report
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting [Yahoo! Finance]
10/3
07:30 am
bctx
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting
Low
Report
BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting